Neuromyelitis optica was previously considered a subtype of multiple sclerosis until a specific serum antibody, NMO-IgG, was discovered in 2004. In 2012, anti-MOG antibody was found specifically in the serum of patients whose presentation was similar to those with neuromyelitis optica. These autoantibodies are pathogenic and are important disease markers when reaching a diagnosis.
|Number of pages||8|
|Journal||Brain and Nerve|
|Publication status||Published - 2018 Apr|
- Multiple sclerosis
- Myelin oligodendrocyte glycoprotein
- Neuromyelitis optica